SarcoMed USA
PrivateCompany Overview
SarcoMed USA is a biotechnology company focused on the development of novel inhaled therapies for pulmonary sarcoidosis and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologypulmonary sarcoidosisinhaled therapyorphan drugdrug developmentclinical trialsrespiratory conditionsDNase 1 therapybiosimilar505(b)(2) pathwayrare diseasebiotech startupdrug licensingpulmonary medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SarcoMed USA Comparables
Compare SarcoMed USA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xentria, Inc. | 78% | |
| aTyr Pharma | 76% | |
| MSICS Pharma | 74% | |
SarcoMed USA Funding Rounds
Historical fundraising activity
SarcoMed USA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SarcoMed USA's valuation, stock price, and market status.
See something wrong or outdated?